The advantages of [18F]MK-6240 include higher affinity to tau aggregates, more sensitive detection of tau in early AD progression, and greater dynamic range in standardized uptake value ratio (SUVR) estimates [4, 20]. The gene discussed is MAPT; the disease is Alzheimer disease.